214 related articles for article (PubMed ID: 21912473)
1. Influence of irritable bowel syndrome on treatment outcome in gastroesophageal reflux disease.
Mönnikes H; Heading RC; Schmitt H; Doerfler H
World J Gastroenterol; 2011 Jul; 17(27):3235-41. PubMed ID: 21912473
[TBL] [Abstract][Full Text] [Related]
2. Possible etiology of improvements in both quality of life and overlapping gastroesophageal reflux disease by proton pump inhibitor treatment in a prospective randomized controlled trial.
Mönnikes H; Schwan T; van Rensburg C; Straszak A; Theek C; Lühmann R; Sander P; Tholen A
BMC Gastroenterol; 2013 Oct; 13():145. PubMed ID: 24083350
[TBL] [Abstract][Full Text] [Related]
3. Randomised clinical trial: sustained response to PPI treatment of symptoms resembling functional dyspepsia and irritable bowel syndrome in patients suffering from an overlap with erosive gastro-oesophageal reflux disease.
Mönnikes H; Schwan T; van Rensburg C; Straszak A; Theek C; Sander P; Lühmann R
Aliment Pharmacol Ther; 2012 Jun; 35(11):1279-89. PubMed ID: 22486552
[TBL] [Abstract][Full Text] [Related]
4. The influence of co-morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro-oesophageal reflux disease.
Nojkov B; Rubenstein JH; Adlis SA; Shaw MJ; Saad R; Rai J; Weinman B; Chey WD
Aliment Pharmacol Ther; 2008 Mar; 27(6):473-82. PubMed ID: 18194508
[TBL] [Abstract][Full Text] [Related]
5. Factors influencing treatment outcome in patients with gastroesophageal reflux disease: outcome of a prospective pragmatic trial in Asian patients.
Goh KL; Choi KD; Choi MG; Hsieh TY; Jung HY; Lien HC; Menon J; Mesenas S; Park H; Sheu BS; Wu JC
BMC Gastroenterol; 2014 Sep; 14():156. PubMed ID: 25200403
[TBL] [Abstract][Full Text] [Related]
6. Impact of Comorbid Irritable Bowel Syndrome on Treatment Outcome in Non-Erosive Reflux Disease on Long-Term Proton Pump Inhibitor in Japan.
Funaki Y; Kaneko H; Kawamura Y; Yoshimine T; Tamura Y; Izawa S; Ebi M; Ogasawara N; Sasaki M; Kasugai K
Digestion; 2017; 96(1):39-45. PubMed ID: 28641289
[TBL] [Abstract][Full Text] [Related]
7. Prediction of response to PPI therapy and factors influencing treatment outcome in patients with GORD: a prospective pragmatic trial using pantoprazole.
Heading RC; Mönnikes H; Tholen A; Schmitt H
BMC Gastroenterol; 2011 May; 11():52. PubMed ID: 21569313
[TBL] [Abstract][Full Text] [Related]
8. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
Armstrong D; Paré P; Pericak D; Pyzyk M;
Am J Gastroenterol; 2001 Oct; 96(10):2849-57. PubMed ID: 11695354
[TBL] [Abstract][Full Text] [Related]
9. Dyspepsia and IBS symptoms in patients with NERD, ERD and Barrett's esophagus.
Neumann H; Monkemuller K; Kandulski A; Malfertheiner P
Dig Dis; 2008; 26(3):243-7. PubMed ID: 18463443
[TBL] [Abstract][Full Text] [Related]
10. [Clinical analysis of recurrence rate and symptom improvement in gastro-esophageal reflux disease patients].
Jeong YJ; Lee DH; Choi TH; Hwang TJ; Lee BH; Nah JC; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Kim N; Jung HC; Song IS
Korean J Gastroenterol; 2010 Feb; 55(2):100-8. PubMed ID: 20168056
[TBL] [Abstract][Full Text] [Related]
11. [Long-term impact on quality of life in patients with gastroesophageal reflux disease after 52-week rabeprazole treatment].
Yang XL; Liu XH; Ke MY; Song ZQ; Yuan YZ; Luo JY; Hou XH
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(34):2404-7. PubMed ID: 20137694
[TBL] [Abstract][Full Text] [Related]
12. Efficacy, safety, and tolerability of pantoprazole magnesium in the treatment of reflux symptoms in patients with gastroesophageal reflux disease (GERD): a prospective, multicenter, post-marketing observational study.
Remes-Troche JM; Sobrino-Cossío S; Soto-Pérez JC; Teramoto-Matsubara O; Morales-Arámbula M; Orozco-Gamiz A; Tamayo de la Cuesta JL; Mateos G
Clin Drug Investig; 2014 Feb; 34(2):83-93. PubMed ID: 24347282
[TBL] [Abstract][Full Text] [Related]
13. Bowel symptoms in nonerosive gastroesophageal reflux disease: nature, prevalence, and relation to acid reflux.
Zimmerman J; Hershcovici T
J Clin Gastroenterol; 2008 Mar; 42(3):261-5. PubMed ID: 18223499
[TBL] [Abstract][Full Text] [Related]
14. Onset of relief of symptoms of gastroesophageal reflux disease: post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily.
Haag S; Holtmann G
Clin Ther; 2010 Apr; 32(4):678-90. PubMed ID: 20435237
[TBL] [Abstract][Full Text] [Related]
15. Impact of concomitant dyspepsia and irritable bowel syndrome on symptom burden in patients with gastroesophageal reflux disease.
Lei WY; Chang WC; Wen SH; Wong MW; Hung JS; Yi CH; Liu TT; Hsu CS; Orr WC; Vaezi MF; Pace F; Hsieh TC; Chen CL
J Formos Med Assoc; 2019 Apr; 118(4):797-806. PubMed ID: 30584006
[TBL] [Abstract][Full Text] [Related]
16. Irritable bowel syndrome is associated with gastroesophageal reflux symptom but not erosive esophagitis.
Nam SY; Ryu KH; Park BJ
J Neurogastroenterol Motil; 2013 Oct; 19(4):521-31. PubMed ID: 24199014
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease.
van Zyl J; van Rensburg C; Vieweg W; Fischer R
Digestion; 2004; 70(1):61-9. PubMed ID: 15297779
[TBL] [Abstract][Full Text] [Related]
18. Concomitant irritable bowel syndrome is associated with failure of step-down on-demand proton pump inhibitor treatment in patients with gastro-esophageal reflux disease.
Wu JC; Lai LH; Chow DK; Wong GL; Sung JJ; Chan FK
Neurogastroenterol Motil; 2011 Feb; 23(2):155-60, e31. PubMed ID: 21087355
[TBL] [Abstract][Full Text] [Related]
19. Randomised clinical trial: daily pantoprazole magnesium 40 mg vs. esomeprazole 40 mg for gastro-oesophageal reflux disease, assessed by endoscopy and symptoms.
Moraes-Filho JP; Pedroso M; Quigley EM;
Aliment Pharmacol Ther; 2014 Jan; 39(1):47-56. PubMed ID: 24299323
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of and impact of pantoprazole on nocturnal heartburn and associated sleep complaints in patients with erosive esophagitis.
Kindt S; Imschoot J; Tack J
Dis Esophagus; 2011 Nov; 24(8):531-7. PubMed ID: 21418126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
